Article Information
vol. 8 no. 7, bio042192
- Received February 1, 2019
- Accepted May 19, 2019
- Published online July 2, 2019.
Article Versions
- Previous version (June 10, 2019 - 01:46).
- You are viewing the most recent version of this article.
Author Information
- Shun Nakai1,
- Ima Shibata1,
- Takahiro Shitamichi1,
- Hiroyuki Yamaguchi2,
- Nobuyuki Takagi3,
- Tomoaki Inoue4,
- Toshito Nakagawa4,
- Jumpei Kiyokawa4,
- Satoshi Wakabayashi5,
- Tomoya Miyoshi6,
- Eriko Higashi6,
- Seiichi Ishida7,
- Nobuaki Shiraki1,* and
- Shoen Kume1,*
- 1School of Life Science and Technology, Tokyo Institute of Technology, 4259-B-25 Nagatsuta-cho, Midori-ku, Yokohama, Kanagawa 226-8501, Japan
- 2Isehara Research Laboratory, Technology and Development Division, Kanto Chemical Co., Inc., 21 Suzukawa, Isehara, Kanagawa 259-1146, Japan
- 3Technology and Development Division, Kanto Chemical Co., Inc., 2-1, Nihonbashi Muromachi 2-chome, Chuo-ku, Tokyo 103-0022, Japan
- 4Research Division, Chugai Pharmaceutical Co. Ltd, 1-135 Komakado, Gotemba, Shizuoka 412-8513, Japan
- 5Pharmacokinetics and Metabolism, Drug Safety and Pharmacokinetics Laboratories, Taisho Pharmaceutical Co., Ltd, 1-403 Yoshino-cho, Saitama-shi, Saitama 330-8530, Japan
- 6Toxicology and Pharmacokinetics Laboratories, Pharmaceutical Research Laboratories, Toray Industries, Inc., 6-10-1 Tebiro, Kamakura, Kanagawa 248-8555, Japan
- 7Division of Pharmacology, National Institute of Health Science, 3-25-26 Tonomati, Kawasaki 210-9501, Japan
- ↵*Author for correspondence (skume{at}bio.titech.ac.jp; shiraki{at}bio.titech.ac.jp)
Article usage
Usage statistics are calculated at the beginning of each month for the previous month.
Statistics from Altmetric.com
Article Navigation
Related articles
Cited by...
More in this TOC section
Similar articles
Other journals from The Company of Biologists
Biology Open and COVID-19
We are aware that the COVID-19 pandemic is having an unprecedented impact on researchers worldwide. The Editors of all The Company of Biologists’ journals have been considering ways in which we can alleviate concerns that members of our community may have around publishing activities during this time. Read about the actions we are taking at this time.
Please don’t hesitate to contact the Editorial Office if you have any questions or concerns.
2020 at The Company of Biologists
Despite 2020’s challenges, we achieved a lot at The Company of Biologists. In the midst of the pandemic, we have seen long-term projects and new ventures come to fruition. Read our full lowdown of 2020.
Interview- Sebastian Markert
Sebastian Markert is first author of a paper in BiO using C. elegans to model amyotrophic lateral sclerosis. In an interview, he talks about the potential implications of his work and his future plans.
Three communities to support biologists to everywhere
Online communities have never been more important. If you’re looking for somewhere to meet fellow scientists, take part in topical discussions and find virtual events in your field, take a look at each of our community sites:
- The Node: the community site for and by developmental biologists
- preLights: the preprint highlights service run by the biological community
- FocalPlane: the community site for microscopists and biologists alike